How UCB beat 2 oth­er bid­ders to land $1.9B buy­out of Zo­genix and its epilep­sy drug

Days be­fore it would nail down the FDA’s ap­proval for its epilep­sy drug Fin­tepla, Zo­genix re­ceived one of the first in­quiries from a phar­ma com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.